Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 867.314 million compared to CNY 519.149 million a year ago. Operating income was CNY 247.305 million compared to CNY 50.681 million a year ago. Net income was CNY 197.438 million compared to CNY 47.030 million a year ago. Basic earnings per share from continuing operations was CNY 1.17 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 1.17 compared to CNY 0.31 a year ago.